LAM RESEARCH CORPORATION (LRCX) FY2024 Annual Balance Sheet

Balance Sheet

As of 2024-06-30

Swipe to see the full flow
LAM RESEARCH CORPORATION (LRCX) FY2024 Annual Balance SheetBalance sheet as of 2024-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$4.34 BLiabilities$10.21 BNon-current liabilities$5.87 BCurrent assets$12.88 BEquity$8.54 BAssets$18.74 BGross equity(calculated)$33.04 BNon-current assets$5.86 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsInventoriesAccounts receivable, less allowance of $5,277 as of June 30, 2024 and $5,344 as of June 25, 2023Prepaid expenses and other current assetsProperty and equipment, netOther assetsGoodwillIntangible assets, netAccrued expenses and other current liabilitiesDeferred profitTrade accounts payableCurrent portion of long-term debt and finance lease obligationsLong-term debt and finance lease obligations, less current portionIncome taxes payableOther long-term liabilitiesRetained earningsAdditional paid-in capitalCommon stock, at par value of $0.001 per share; authorized 400,000 shares as of June 30, 2024 and June 25, 2023; issued and outstanding 130,377 shares as of June 30, 2024, and 133,297 shares as of June 25, 2023Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost, 164,824 shares as of June 30, 2024, and 161,380 shares as of June 25, 2023Accumulated other comprehensive lossAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$1.80 BCurrent liabilitiesCurrent liabilities$4.34 BDeferred profitDeferred profit$1.42 BLiabilitiesLiabilities$10.21 BTrade accounts payableTrade accounts payable$613.97 MCurrent portion of long-term debt and finance lease obligationsCurrent portion of long-term debtand finance lease obligations$504.81 MNon-current liabilitiesNon-current liabilities$5.87 BLong-term debt and finance lease obligations, less current portionLong-term debt and finance lease obligations, net$4.48 BCurrent assetsCurrent assets$12.88 BEquityEquity$8.54 BIncome taxes payableIncome taxes payable$813.30 MCash and cash equivalentsCash and cash equivalents$5.85 BAssetsAssets$18.74 BOther long-term liabilitiesOther long-term liabilities$575.01 MGross equity (calculated)Gross equity(calculated)$33.04 BInventoriesInventories$4.22 BAccounts receivable, less allowance of $5,277 as of June 30, 2024 and $5,344 as of June 25, 2023Accounts receivable, net$2.52 BPrepaid expenses and other current assetsPrepaid expenses and other current assets$298.19 MNon-current assetsNon-current assets$5.86 BProperty and equipment, netProperty and equipment, net$2.15 BRetained earningsRetained earnings$24.81 BOther assetsOther assets$1.94 BGoodwillGoodwill$1.63 BIntangible assets, netIntangible assets, net$138.55 MAdditional paid-in capitalAdditional paid-in capital$8.23 BCommon stock, at par value of $0.001 per share; authorized 400,000 shares as of June 30, 2024 and June 25, 2023; issued and outstanding 130,377 shares as of June 30, 2024, and 133,297 shares as of June 25, 2023Common stock$130.00 KTreasury stock, at cost, 164,824 shares as of June 30, 2024, and 161,380 shares as of June 25, 2023Treasury stock−$24.37 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$130.43 M
Chart details

LAM RESEARCH CORPORATION (LRCX) FY2024 Annual Balance Sheet

Balance sheet as of 2024-06-30. The chart shows assets, liabilities and equity at that date.

Assets
18,744,728,000 US dollars
Current assets
12,883,220,000 US dollars
Non-current assets
5,861,508,000 US dollars
Liabilities
10,205,274,000 US dollars
Current liabilities
4,338,438,000 US dollars
Non-current liabilities
5,866,836,000 US dollars
Equity
8,539,454,000 US dollars
Cash and cash equivalents
5,847,856,000 US dollars
Inventories
4,217,924,000 US dollars
Accounts receivable, less allowance of $5,277 as of June 30, 2024 and $5,344 as of June 25, 2023
2,519,250,000 US dollars
Prepaid expenses and other current assets
298,190,000 US dollars
Property and equipment, net
2,154,518,000 US dollars
Other assets
1,941,917,000 US dollars
Goodwill
1,626,528,000 US dollars
Intangible assets, net
138,545,000 US dollars
Accrued expenses and other current liabilities
1,801,877,000 US dollars
Deferred profit
1,417,781,000 US dollars
Trade accounts payable
613,966,000 US dollars
Current portion of long-term debt and finance lease obligations
504,814,000 US dollars
Long-term debt and finance lease obligations, less current portion
4,478,520,000 US dollars
Income taxes payable
813,304,000 US dollars
Other long-term liabilities
575,012,000 US dollars
Retained earnings
24,811,315,000 US dollars
Additional paid-in capital
8,225,303,000 US dollars
Common stock, at par value of $0.001 per share; authorized 400,000 shares as of June 30, 2024 and June 25, 2023; issued and outstanding 130,377 shares as of June 30, 2024, and 133,297 shares as of June 25, 2023
130,000 US dollars
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding
0 US dollars
Treasury stock, at cost, 164,824 shares as of June 30, 2024, and 161,380 shares as of June 25, 2023
negative 24,366,866,000 US dollars
Accumulated other comprehensive loss
negative 130,428,000 US dollars
Gross equity (calculated)
33,036,748,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
LAM RESEARCH CORPORATION (LRCX) FY2024 Annual Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!